TCM
AXSM icon

Tang Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Tang Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-320,000
Closed -$25.5M – 104
2023
Q4 		$25.5M Hold
320,000
– – 2.35% 11
2023
Q3 		$22.4M Hold
320,000
– – 3.16% 8
2023
Q2 		$23M Hold
320,000
– – 3.39% 8
2023
Q1 		$19.7M Hold
320,000
– – 2.94% 10
2022
Q4 		$24.7M Buy
320,000
+250,000
+357% +$14.9M 3.59% 7
2022
Q3 		$3.12M Buy
+70,000
New +$3.5M 0.38% 60

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tang Capital Management's AXSM Position: Q1 2024 in Review

Tang Capital Management sold out of Axsome Therapeutics (AXSM) in Q1 2024, closing a stake of 320,000 shares — an estimated $25.5M sold.

Tang Capital Management first reported a position in AXSM in Q3 2022 and held it in 6 quarters. The position peaked at $25.5M in Q4 2023. 260 funds tracked by Wall St. Rank hold AXSM as of Q1 2024.

  • Tang Capital Management reported no remaining Axsome Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Tang Capital Management sold 320,000 Axsome Therapeutics shares in Q1 2024, an estimated $25.5M.
  • Tang Capital Management first reported a position in Axsome Therapeutics in Q3 2022 and held it in 6 quarters.
  • Tang Capital Management's Axsome Therapeutics position peaked at $25.5M in Q4 2023.
  • 260 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2024.

Based on Tang Capital Management's 13F filing for Q1 2024, filed 15 May 2024.